|
JP5546860B2
(ja)
*
|
2006-08-16 |
2014-07-09 |
ノバルティス アーゲー |
高結晶性治療化合物の固体分散体を製造するための方法
|
|
KR101525132B1
(ko)
*
|
2008-10-08 |
2015-06-02 |
포항공과대학교 산학협력단 |
Ｘ 선용 조영제 캡슐 및 이의 제조방법
|
|
US20100233270A1
(en)
|
2009-01-08 |
2010-09-16 |
Northwestern University |
Delivery of Oligonucleotide-Functionalized Nanoparticles
|
|
KR101648960B1
(ko)
*
|
2011-04-15 |
2016-08-22 |
서울대학교산학협력단 |
접합 물질과 코티닌과의 접합체에 항-코티닌 항체가 결합된 복합체 및 이의 용도
|
|
CA2850198A1
(en)
*
|
2011-09-30 |
2013-04-04 |
Mallinckrodt Llc |
Remote assembly of targeted nanoparticles using complementary oligonucleotide linkers
|
|
RU2493848C1
(ru)
*
|
2012-06-14 |
2013-09-27 |
Геннадий Петрович Власов |
Биодеградируемый полимерный носитель для доставки противоопухолевого лекарственного средства (варианты)
|
|
WO2014152211A1
(en)
|
2013-03-14 |
2014-09-25 |
Moderna Therapeutics, Inc. |
Formulation and delivery of modified nucleoside, nucleotide, and nucleic acid compositions
|
|
EP3041934A1
(en)
|
2013-09-03 |
2016-07-13 |
Moderna Therapeutics, Inc. |
Chimeric polynucleotides
|
|
WO2015034925A1
(en)
|
2013-09-03 |
2015-03-12 |
Moderna Therapeutics, Inc. |
Circular polynucleotides
|
|
EP3052521A1
(en)
|
2013-10-03 |
2016-08-10 |
Moderna Therapeutics, Inc. |
Polynucleotides encoding low density lipoprotein receptor
|
|
US10182988B2
(en)
|
2013-12-03 |
2019-01-22 |
Northwestern University |
Liposomal particles, methods of making same and uses thereof
|
|
TR201908550T4
(tr)
|
2014-06-04 |
2019-07-22 |
Exicure Inc |
Profilaktik veya terapötik uygulamalar için lipozomal sferik nükleik asitler tarafından immün modülatörlerin çok değerlikli teslimi.
|
|
US20170204152A1
(en)
|
2014-07-16 |
2017-07-20 |
Moderna Therapeutics, Inc. |
Chimeric polynucleotides
|
|
EP3171895A1
(en)
|
2014-07-23 |
2017-05-31 |
Modernatx, Inc. |
Modified polynucleotides for the production of intrabodies
|
|
JP6595232B2
(ja)
|
2015-07-02 |
2019-10-23 |
ソニー・オリンパスメディカルソリューションズ株式会社 |
内視鏡用撮像装置、内視鏡装置、及び内視鏡用ケーブル
|
|
KR101704379B1
(ko)
*
|
2015-10-27 |
2017-02-08 |
(주)알테오젠 |
항체-약물 접합체 및 그 제조방법
|
|
CN108697815A
(zh)
*
|
2016-02-10 |
2018-10-23 |
辉瑞公司 |
具有egfr配体的治疗性纳米颗粒及其制备和使用方法
|
|
KR101856838B1
(ko)
*
|
2016-02-17 |
2018-06-19 |
이희정 |
베타-아밀로이드 올리고머에 대한 압타머 및 이의 용도
|
|
EP3452598A4
(en)
*
|
2016-05-06 |
2020-04-29 |
Exicure, Inc. |
LIPOSOMAL SPHERICAL NUCLEIC ACID (ANS) CONSTRUCTS HAVING ANTISENSE OLIGONUCLEOTIDES (ASO) FOR THE SPECIFIC INACTIVATION OF INTERLEUKIN 17 RECEPTOR RNA
|
|
KR102015524B1
(ko)
*
|
2016-12-26 |
2019-08-29 |
인터올리고 주식회사 |
압타머-약물 콘쥬게이트 및 그 용도
|
|
US11696954B2
(en)
|
2017-04-28 |
2023-07-11 |
Exicure Operating Company |
Synthesis of spherical nucleic acids using lipophilic moieties
|
|
US11485972B2
(en)
|
2017-05-18 |
2022-11-01 |
Modernatx, Inc. |
Modified messenger RNA comprising functional RNA elements
|
|
JP7285220B2
(ja)
|
2017-05-18 |
2023-06-01 |
モデルナティエックス インコーポレイテッド |
連結したインターロイキン－１２（ｉｌ１２）ポリペプチドをコードするポリヌクレオチドを含む脂質ナノ粒子
|
|
EP3638292A1
(en)
|
2017-06-14 |
2020-04-22 |
ModernaTX, Inc. |
Polynucleotides encoding coagulation factor viii
|
|
WO2019010418A1
(en)
*
|
2017-07-07 |
2019-01-10 |
Drexel University |
THERAPEUTIC, DIAGNOSTIC AND / OR THERANOSTIC CONSTRUCTS ACTIVATED BY VOLTAGE
|
|
CN107998080A
(zh)
*
|
2017-11-21 |
2018-05-08 |
东南大学 |
一种偶联抗体的主动靶向载药长循环脂质体及其制备方法
|
|
CA3079428A1
(en)
|
2017-11-22 |
2019-05-31 |
Modernatx, Inc. |
Polynucleotides encoding ornithine transcarbamylase for the treatment of urea cycle disorders
|
|
US11939601B2
(en)
|
2017-11-22 |
2024-03-26 |
Modernatx, Inc. |
Polynucleotides encoding phenylalanine hydroxylase for the treatment of phenylketonuria
|
|
EP3714045A1
(en)
|
2017-11-22 |
2020-09-30 |
Modernatx, Inc. |
Polynucleotides encoding propionyl-coa carboxylase alpha and beta subunits for the treatment of propionic acidemia
|
|
MA51523A
(fr)
|
2018-01-05 |
2020-11-11 |
Modernatx Inc |
Polynucléotides codant pour des anticorps anti-virus du chikungunya
|
|
US11007211B2
(en)
*
|
2018-01-07 |
2021-05-18 |
City Of Hope |
CCR7 aptamers and uses thereof
|
|
WO2019141267A1
(zh)
*
|
2018-01-22 |
2019-07-25 |
北京茵诺医药科技有限公司 |
用于靶向活化cd44分子的重组仿生纳米载体递送系统、其制备方法和用途
|
|
KR101977532B1
(ko)
*
|
2018-03-09 |
2019-05-10 |
연세대학교 원주산학협력단 |
약물, 양자점 및 표적화제를 포함하는 나노 마이셀 및 이의 용도
|
|
WO2019226650A1
(en)
|
2018-05-23 |
2019-11-28 |
Modernatx, Inc. |
Delivery of dna
|
|
US20220184185A1
(en)
|
2018-07-25 |
2022-06-16 |
Modernatx, Inc. |
Mrna based enzyme replacement therapy combined with a pharmacological chaperone for the treatment of lysosomal storage disorders
|
|
WO2020047201A1
(en)
|
2018-09-02 |
2020-03-05 |
Modernatx, Inc. |
Polynucleotides encoding very long-chain acyl-coa dehydrogenase for the treatment of very long-chain acyl-coa dehydrogenase deficiency
|
|
MX2021003015A
(es)
|
2018-09-13 |
2021-07-15 |
Modernatx Inc |
Polinucleotidos que codifican glucosa-6-fosfatasa para el tratamiento de la glucogenosis.
|
|
WO2020056155A2
(en)
|
2018-09-13 |
2020-03-19 |
Modernatx, Inc. |
Polynucleotides encoding branched-chain alpha-ketoacid dehydrogenase complex e1-alpha, e1-beta, and e2 subunits for the treatment of maple syrup urine disease
|
|
JP2022500444A
(ja)
|
2018-09-14 |
2022-01-04 |
モダーナティエックス・インコーポレイテッドModernaTX, Inc. |
クリグラー−ナジャー症候群の治療のためのウリジン二リン酸グリコシルトランスフェラーゼ１ファミリー、ポリペプチドａ１をコードするポリヌクレオチド
|
|
EP3856233A1
(en)
|
2018-09-27 |
2021-08-04 |
Modernatx, Inc. |
Polynucleotides encoding arginase 1 for the treatment of arginase deficiency
|
|
JP2022532078A
(ja)
|
2019-05-08 |
2022-07-13 |
アストラゼネカ アクチボラグ |
皮膚及び創傷のための組成物並びにその使用の方法
|
|
WO2020241454A1
(ja)
*
|
2019-05-31 |
2020-12-03 |
株式会社新日本科学 |
クロマトグラフ質量分析装置を用いた質量分析方法
|
|
CN110787149A
(zh)
*
|
2019-11-12 |
2020-02-14 |
深圳碳十四科技创新有限公司 |
双壳层纳米粒子及其制备方法
|
|
EP4158005A1
(en)
|
2020-06-01 |
2023-04-05 |
ModernaTX, Inc. |
Phenylalanine hydroxylase variants and uses thereof
|
|
WO2022038605A1
(en)
*
|
2020-08-20 |
2022-02-24 |
Bionanosim (Bns) Ltd |
Lipid delivery systems for delivery of oxaliplatin palmitate acetate
|
|
WO2022104131A1
(en)
|
2020-11-13 |
2022-05-19 |
Modernatx, Inc. |
Polynucleotides encoding cystic fibrosis transmembrane conductance regulator for the treatment of cystic fibrosis
|
|
WO2022204370A1
(en)
|
2021-03-24 |
2022-09-29 |
Modernatx, Inc. |
Lipid nanoparticles and polynucleotides encoding ornithine transcarbamylase for the treatment of ornithine transcarbamylase deficiency
|
|
WO2022204390A1
(en)
|
2021-03-24 |
2022-09-29 |
Modernatx, Inc. |
Lipid nanoparticles containing polynucleotides encoding phenylalanine hydroxylase and uses thereof
|
|
US20240207374A1
(en)
|
2021-03-24 |
2024-06-27 |
Modernatx, Inc. |
Lipid nanoparticles containing polynucleotides encoding glucose-6-phosphatase and uses thereof
|
|
US20240216288A1
(en)
|
2021-03-24 |
2024-07-04 |
Modernatx, Inc. |
Lipid nanoparticles containing polynucleotides encoding propionyl-coa carboxylase alpha and beta subunits and uses thereof
|
|
US20240226025A1
(en)
|
2021-03-24 |
2024-07-11 |
Modernatx, Inc. |
Polynucleotides encoding methylmalonyl-coa mutase for the treatment of methylmalonic acidemia
|
|
EP4355882A2
(en)
|
2021-06-15 |
2024-04-24 |
Modernatx, Inc. |
Engineered polynucleotides for cell-type or microenvironment-specific expression
|
|
WO2022271776A1
(en)
|
2021-06-22 |
2022-12-29 |
Modernatx, Inc. |
Polynucleotides encoding uridine diphosphate glycosyltransferase 1 family, polypeptide a1 for the treatment of crigler-najjar syndrome
|
|
WO2023056044A1
(en)
|
2021-10-01 |
2023-04-06 |
Modernatx, Inc. |
Polynucleotides encoding relaxin for the treatment of fibrosis and/or cardiovascular disease
|
|
US20250221931A1
(en)
|
2022-03-25 |
2025-07-10 |
Modernatx, Inc. |
Polynucleotides encoding fanconi anemia, complementation group proteins for the treatment of fanconi anemia
|
|
WO2023215616A2
(en)
*
|
2022-05-05 |
2023-11-09 |
Aion Healthspan, Inc. |
Nanomaterial-stem cell compositions and methods of use
|
|
WO2024026254A1
(en)
|
2022-07-26 |
2024-02-01 |
Modernatx, Inc. |
Engineered polynucleotides for temporal control of expression
|
|
WO2024130158A1
(en)
|
2022-12-16 |
2024-06-20 |
Modernatx, Inc. |
Lipid nanoparticles and polynucleotides encoding extended serum half-life interleukin-22 for the treatment of metabolic disease
|
|
WO2024182301A2
(en)
|
2023-02-27 |
2024-09-06 |
Modernatx, Inc. |
Lipid nanoparticles and polynucleotides encoding galactose-1-phosphate uridylyltransferase (galt) for the treatment of galactosemia
|
|
WO2024197033A1
(en)
|
2023-03-21 |
2024-09-26 |
Modernatx, Inc. |
Polynucleotides encoding relaxin for the treatment of heart failure
|
|
EP4704816A1
(en)
|
2023-05-03 |
2026-03-11 |
ModernaTX, Inc. |
Polynucleotides encoding cystic fibrosis transmembrane conductance regulator for the treatment of cystic fibrosis
|
|
WO2025072482A1
(en)
|
2023-09-27 |
2025-04-03 |
Modernatx, Inc. |
Immunoglobulin a protease polypeptides, polynucleotides, and uses thereof
|
|
WO2025255199A1
(en)
|
2024-06-05 |
2025-12-11 |
Modernatx, Inc. |
Argininosuccinate synthase 1 and argininosuccinate lyase polypeptides and polynucleotides and uses thereof
|